<DOC>
	<DOCNO>NCT00584935</DOCNO>
	<brief_summary>Cicatricial pemphigoid autoimmune blister disease affect skin , mucous membrane , , small subset patient , eye . Progressive ocular disease lead irreversible damage blindness . Conventional treatment include systemic steroid , dapsone , immunosuppressive agent . These treatment , however , successful patient . Ritumimab effective treatment autoimmune disorder , recently show effective autoimmune blister pemphigus . We propose also effective treatment cicatricial pemphigoid .</brief_summary>
	<brief_title>Clinical Trial Evaluating Rituximab Ocular Cicatricial Pemphigoid</brief_title>
	<detailed_description>Cicatricial pemphigoid autoimmune blister disease whcih affect skin , mucous membrane , , small subset patient , eye . Progressive ocular disease lead irreversible damage blindness . Conventional treatment include high dose systemic steroid , dapsone , immunosuppressive agent azathioprine , methotrexate , cyclophosphamide , mycophenolate mofetil . However , subgroup patient fail respond treatment , develop intolerable side effect , contraindication use . Patients may also develop resistance conventional treatment modality . For reason , alternative treatment modality need . Rituximab effective treatment autoimmune disorder . It recently show effective treatment another autoimmune blister disorder know pemphigus . We thus propose Rituximab effective treatment cicatricial pemphigoid .</detailed_description>
	<mesh_term>Pemphigoid , Bullous</mesh_term>
	<mesh_term>Pemphigoid , Benign Mucous Membrane</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<criteria>1 . Clinical diagnosis ocular cicatricial pemphigoid ( symptoms conjuctivitis , irritation , burning , increased lacrimation , photophobia , dryness eye along conjunctival inflammation , trichiasis , scar 2 . One follow : Failed response use one conventional treatment minimum 10 week ; Minimal conventional medication dos , significant adverse effect , contradiction use , progressive disease despite treatment 3 . Adults age 19 old 4 . Adequate renal function indicate serum creatinine level le 1.5 1. know hypersensitivity rituximab component 2 . Age le 19 year 3 . Any condition deem investigator significant hazard subject investigational therapy initiate .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Pemphigoid</keyword>
	<keyword>Blistering Diseases</keyword>
	<keyword>Blindness</keyword>
	<keyword>Autoimmune</keyword>
	<keyword>Rituximab</keyword>
</DOC>